世界のトラスツズマブ注射市場予測 2023年-2029年

【英語タイトル】Global Trastuzumab Injection Market Growth 2023-2029

LP Informationが出版した調査資料(LP23DC01521)・商品コード:LP23DC01521
・発行会社(調査会社):LP Information
・発行日:2023年11月(※2025年版があります。お問い合わせください。)
・ページ数:102
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後2-3営業日)
・調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野:医薬品&医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,660 ⇒換算¥519,720見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,490 ⇒換算¥779,580見積依頼/購入/質問フォーム
Corporate User(閲覧人数制限なし)USD7,320 ⇒換算¥1,039,440見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界のトラスツズマブ注射市場」は、過去の販売実績から2022年の世界のトラスツズマブ注射の総販売量を検討し、2023年から2029年の予測されるトラスツズマブ注射の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別のトラスツズマブ注射の市場規模を掲載し、XXX百万米ドル規模の世界のトラスツズマブ注射市場の詳細な分析を提供します。本インサイトレポートは、世界のトラスツズマブ注射業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界のトラスツズマブ注射市場における各社の独自のポジションをより深く理解するために、トラスツズマブ注射製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界のトラスツズマブ注射市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。トラスツズマブ注射の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000%と予測されています。トラスツズマブ注射の中国市場は、2023年から2029年までの年平均000%成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。トラスツズマブ注射のヨーロッパ市場は、2023年から2029年にかけて年平均000%成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

トラスツズマブ注射の世界主要メーカーとしては、Pfizer、 Roche、 Celltrion、 Amgen、 Samsung Bioepsis、 Mylan、 Glenmark、 AstraZeneca、 Remegen Co., Ltd.、 Hisun Biopharmaceutical、 Shanghai Henlius Biotechなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000%のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別のトラスツズマブ注射市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査ではトラスツズマブ注射市場をセグメンテーションし、種類別 (60mg、150mg、440mg、その他)、用途別 (病院、診療所、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分:60mg、150mg、440mg、その他

・用途別区分:病院、診療所、その他

・地域別区分
南北アメリカ(アメリカ、カナダ、メキシコ、ブラジル)
アジア太平洋(中国、日本、韓国、東南アジア、インド、オーストラリア)
ヨーロッパ(ドイツ、フランス、イギリス、イタリア、ロシア)
中東・アフリカ(エジプト、南アフリカ、イスラエル、トルコ、GCC諸国)

【本レポートで扱う主な質問】

・世界のトラスツズマブ注射市場の10年間の市場状況・展望は?
・世界および地域別に見たトラスツズマブ注射市場成長の要因は何か?
・トラスツズマブ注射の市場機会はエンドマーケットの規模によってどのように変化するのか?
・トラスツズマブ注射のタイプ別、用途別の内訳は?
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は?

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要:トラスツズマブ注射の年間販売量2018-2029、地域別現状・将来分析
・トラスツズマブ注射の種類別セグメント:60mg、150mg、440mg、その他
・トラスツズマブ注射の種類別販売量:2018-2023年の販売量、売上、市場シェア、販売価格
・トラスツズマブ注射の用途別セグメント:病院、診療所、その他
・トラスツズマブ注射の用途別販売量:2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界のトラスツズマブ注射市場
・企業別のグローバルトラスツズマブ注射市場データ:2018-2023年の年間販売量、市場シェア
・企業別のトラスツズマブ注射の年間売上:2018-2023年の売上、市場シェア
・企業別のトラスツズマブ注射販売価格
・主要企業のトラスツズマブ注射生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

トラスツズマブ注射の地域別レビュー
・地域別のトラスツズマブ注射市場規模2018-2023:年間販売量、売上
・主要国別のトラスツズマブ注射市場規模2018-2023:年間販売量、売上
・南北アメリカのトラスツズマブ注射販売の成長
・アジア太平洋のトラスツズマブ注射販売の成長
・ヨーロッパのトラスツズマブ注射販売の成長
・中東・アフリカのトラスツズマブ注射販売の成長

南北アメリカ市場
・南北アメリカの国別のトラスツズマブ注射販売量、売上(2018-2023)
・南北アメリカのトラスツズマブ注射の種類別販売量
・南北アメリカのトラスツズマブ注射の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別のトラスツズマブ注射販売量、売上(2018-2023)
・アジア太平洋のトラスツズマブ注射の種類別販売量
・アジア太平洋のトラスツズマブ注射の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別のトラスツズマブ注射販売量、売上(2018-2023)
・ヨーロッパのトラスツズマブ注射の種類別販売量
・ヨーロッパのトラスツズマブ注射の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別のトラスツズマブ注射販売量、売上(2018-2023)
・中東・アフリカのトラスツズマブ注射の種類別販売量
・中東・アフリカのトラスツズマブ注射の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・トラスツズマブ注射の製造コスト構造分析
・トラスツズマブ注射の製造プロセス分析
・トラスツズマブ注射の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル:直接販売チャンネル、間接販売チャンネル
・トラスツズマブ注射の主要なグローバル販売業者
・トラスツズマブ注射の主要なグローバル顧客

地域別のトラスツズマブ注射市場予測レビュー
・地域別のトラスツズマブ注射市場規模予測(2024-2029)
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・トラスツズマブ注射の種類別市場規模予測
・トラスツズマブ注射の用途別市場規模予測

主要企業分析
Pfizer、 Roche、 Celltrion、 Amgen、 Samsung Bioepsis、 Mylan、 Glenmark、 AstraZeneca、 Remegen Co., Ltd.、 Hisun Biopharmaceutical、 Shanghai Henlius Biotech
・企業情報
・トラスツズマブ注射製品
・トラスツズマブ注射販売量、売上、価格、粗利益(2018-2023)
・主要ビジネス概要
・最新動向

調査結果および結論

The global Trastuzumab Injection market size is projected to grow from US$ 1222.8 million in 2022 to US$ 1778.6 million in 2029; it is expected to grow at a CAGR of 5.5% from 2023 to 2029.
United States market for Trastuzumab Injection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Trastuzumab Injection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Trastuzumab Injection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Trastuzumab Injection players cover Pfizer, Roche, Celltrion, Amgen, Samsung Bioepsis, Mylan, Glenmark, AstraZeneca and Remegen Co., Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)’ newest research report, the “Trastuzumab Injection Industry Forecast” looks at past sales and reviews total world Trastuzumab Injection sales in 2022, providing a comprehensive analysis by region and market sector of projected Trastuzumab Injection sales for 2023 through 2029. With Trastuzumab Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Trastuzumab Injection industry.
This Insight Report provides a comprehensive analysis of the global Trastuzumab Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Trastuzumab Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Trastuzumab Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Trastuzumab Injection and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Trastuzumab Injection.
This report presents a comprehensive overview, market shares, and growth opportunities of Trastuzumab Injection market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
60 mg
150 mg
440 mg
Others
Segmentation by application
Hospitals
Clinics
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Pfizer
Roche
Celltrion
Amgen
Samsung Bioepsis
Mylan
Glenmark
AstraZeneca
Remegen Co., Ltd.
Hisun Biopharmaceutical
Shanghai Henlius Biotech
Key Questions Addressed in this Report
What is the 10-year outlook for the global Trastuzumab Injection market?
What factors are driving Trastuzumab Injection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Trastuzumab Injection market opportunities vary by end market size?
How does Trastuzumab Injection break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Trastuzumab Injection Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Trastuzumab Injection by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Trastuzumab Injection by Country/Region, 2018, 2022 & 2029
2.2 Trastuzumab Injection Segment by Type
2.2.1 60 mg
2.2.2 150 mg
2.2.3 440 mg
2.2.4 Others
2.3 Trastuzumab Injection Sales by Type
2.3.1 Global Trastuzumab Injection Sales Market Share by Type (2018-2023)
2.3.2 Global Trastuzumab Injection Revenue and Market Share by Type (2018-2023)
2.3.3 Global Trastuzumab Injection Sale Price by Type (2018-2023)
2.4 Trastuzumab Injection Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 Trastuzumab Injection Sales by Application
2.5.1 Global Trastuzumab Injection Sale Market Share by Application (2018-2023)
2.5.2 Global Trastuzumab Injection Revenue and Market Share by Application (2018-2023)
2.5.3 Global Trastuzumab Injection Sale Price by Application (2018-2023)
3 Global Trastuzumab Injection by Company
3.1 Global Trastuzumab Injection Breakdown Data by Company
3.1.1 Global Trastuzumab Injection Annual Sales by Company (2018-2023)
3.1.2 Global Trastuzumab Injection Sales Market Share by Company (2018-2023)
3.2 Global Trastuzumab Injection Annual Revenue by Company (2018-2023)
3.2.1 Global Trastuzumab Injection Revenue by Company (2018-2023)
3.2.2 Global Trastuzumab Injection Revenue Market Share by Company (2018-2023)
3.3 Global Trastuzumab Injection Sale Price by Company
3.4 Key Manufacturers Trastuzumab Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Trastuzumab Injection Product Location Distribution
3.4.2 Players Trastuzumab Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Trastuzumab Injection by Geographic Region
4.1 World Historic Trastuzumab Injection Market Size by Geographic Region (2018-2023)
4.1.1 Global Trastuzumab Injection Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Trastuzumab Injection Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Trastuzumab Injection Market Size by Country/Region (2018-2023)
4.2.1 Global Trastuzumab Injection Annual Sales by Country/Region (2018-2023)
4.2.2 Global Trastuzumab Injection Annual Revenue by Country/Region (2018-2023)
4.3 Americas Trastuzumab Injection Sales Growth
4.4 APAC Trastuzumab Injection Sales Growth
4.5 Europe Trastuzumab Injection Sales Growth
4.6 Middle East & Africa Trastuzumab Injection Sales Growth
5 Americas
5.1 Americas Trastuzumab Injection Sales by Country
5.1.1 Americas Trastuzumab Injection Sales by Country (2018-2023)
5.1.2 Americas Trastuzumab Injection Revenue by Country (2018-2023)
5.2 Americas Trastuzumab Injection Sales by Type
5.3 Americas Trastuzumab Injection Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Trastuzumab Injection Sales by Region
6.1.1 APAC Trastuzumab Injection Sales by Region (2018-2023)
6.1.2 APAC Trastuzumab Injection Revenue by Region (2018-2023)
6.2 APAC Trastuzumab Injection Sales by Type
6.3 APAC Trastuzumab Injection Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Trastuzumab Injection by Country
7.1.1 Europe Trastuzumab Injection Sales by Country (2018-2023)
7.1.2 Europe Trastuzumab Injection Revenue by Country (2018-2023)
7.2 Europe Trastuzumab Injection Sales by Type
7.3 Europe Trastuzumab Injection Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Trastuzumab Injection by Country
8.1.1 Middle East & Africa Trastuzumab Injection Sales by Country (2018-2023)
8.1.2 Middle East & Africa Trastuzumab Injection Revenue by Country (2018-2023)
8.2 Middle East & Africa Trastuzumab Injection Sales by Type
8.3 Middle East & Africa Trastuzumab Injection Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Trastuzumab Injection
10.3 Manufacturing Process Analysis of Trastuzumab Injection
10.4 Industry Chain Structure of Trastuzumab Injection
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Trastuzumab Injection Distributors
11.3 Trastuzumab Injection Customer
12 World Forecast Review for Trastuzumab Injection by Geographic Region
12.1 Global Trastuzumab Injection Market Size Forecast by Region
12.1.1 Global Trastuzumab Injection Forecast by Region (2024-2029)
12.1.2 Global Trastuzumab Injection Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Trastuzumab Injection Forecast by Type
12.7 Global Trastuzumab Injection Forecast by Application
13 Key Players Analysis
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Trastuzumab Injection Product Portfolios and Specifications
13.1.3 Pfizer Trastuzumab Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Roche
13.2.1 Roche Company Information
13.2.2 Roche Trastuzumab Injection Product Portfolios and Specifications
13.2.3 Roche Trastuzumab Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Roche Main Business Overview
13.2.5 Roche Latest Developments
13.3 Celltrion
13.3.1 Celltrion Company Information
13.3.2 Celltrion Trastuzumab Injection Product Portfolios and Specifications
13.3.3 Celltrion Trastuzumab Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Celltrion Main Business Overview
13.3.5 Celltrion Latest Developments
13.4 Amgen
13.4.1 Amgen Company Information
13.4.2 Amgen Trastuzumab Injection Product Portfolios and Specifications
13.4.3 Amgen Trastuzumab Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Amgen Main Business Overview
13.4.5 Amgen Latest Developments
13.5 Samsung Bioepsis
13.5.1 Samsung Bioepsis Company Information
13.5.2 Samsung Bioepsis Trastuzumab Injection Product Portfolios and Specifications
13.5.3 Samsung Bioepsis Trastuzumab Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Samsung Bioepsis Main Business Overview
13.5.5 Samsung Bioepsis Latest Developments
13.6 Mylan
13.6.1 Mylan Company Information
13.6.2 Mylan Trastuzumab Injection Product Portfolios and Specifications
13.6.3 Mylan Trastuzumab Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Mylan Main Business Overview
13.6.5 Mylan Latest Developments
13.7 Glenmark
13.7.1 Glenmark Company Information
13.7.2 Glenmark Trastuzumab Injection Product Portfolios and Specifications
13.7.3 Glenmark Trastuzumab Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Glenmark Main Business Overview
13.7.5 Glenmark Latest Developments
13.8 AstraZeneca
13.8.1 AstraZeneca Company Information
13.8.2 AstraZeneca Trastuzumab Injection Product Portfolios and Specifications
13.8.3 AstraZeneca Trastuzumab Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 AstraZeneca Main Business Overview
13.8.5 AstraZeneca Latest Developments
13.9 Remegen Co., Ltd.
13.9.1 Remegen Co., Ltd. Company Information
13.9.2 Remegen Co., Ltd. Trastuzumab Injection Product Portfolios and Specifications
13.9.3 Remegen Co., Ltd. Trastuzumab Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Remegen Co., Ltd. Main Business Overview
13.9.5 Remegen Co., Ltd. Latest Developments
13.10 Hisun Biopharmaceutical
13.10.1 Hisun Biopharmaceutical Company Information
13.10.2 Hisun Biopharmaceutical Trastuzumab Injection Product Portfolios and Specifications
13.10.3 Hisun Biopharmaceutical Trastuzumab Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Hisun Biopharmaceutical Main Business Overview
13.10.5 Hisun Biopharmaceutical Latest Developments
13.11 Shanghai Henlius Biotech
13.11.1 Shanghai Henlius Biotech Company Information
13.11.2 Shanghai Henlius Biotech Trastuzumab Injection Product Portfolios and Specifications
13.11.3 Shanghai Henlius Biotech Trastuzumab Injection Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Shanghai Henlius Biotech Main Business Overview
13.11.5 Shanghai Henlius Biotech Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Trastuzumab Injection Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Trastuzumab Injection Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 60 mg
Table 4. Major Players of 150 mg
Table 5. Major Players of 440 mg
Table 6. Major Players of Others
Table 7. Global Trastuzumab Injection Sales by Type (2018-2023) & (K Units)
Table 8. Global Trastuzumab Injection Sales Market Share by Type (2018-2023)
Table 9. Global Trastuzumab Injection Revenue by Type (2018-2023) & ($ million)
Table 10. Global Trastuzumab Injection Revenue Market Share by Type (2018-2023)
Table 11. Global Trastuzumab Injection Sale Price by Type (2018-2023) & (US$/Unit)
Table 12. Global Trastuzumab Injection Sales by Application (2018-2023) & (K Units)
Table 13. Global Trastuzumab Injection Sales Market Share by Application (2018-2023)
Table 14. Global Trastuzumab Injection Revenue by Application (2018-2023)
Table 15. Global Trastuzumab Injection Revenue Market Share by Application (2018-2023)
Table 16. Global Trastuzumab Injection Sale Price by Application (2018-2023) & (US$/Unit)
Table 17. Global Trastuzumab Injection Sales by Company (2018-2023) & (K Units)
Table 18. Global Trastuzumab Injection Sales Market Share by Company (2018-2023)
Table 19. Global Trastuzumab Injection Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Trastuzumab Injection Revenue Market Share by Company (2018-2023)
Table 21. Global Trastuzumab Injection Sale Price by Company (2018-2023) & (US$/Unit)
Table 22. Key Manufacturers Trastuzumab Injection Producing Area Distribution and Sales Area
Table 23. Players Trastuzumab Injection Products Offered
Table 24. Trastuzumab Injection Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Trastuzumab Injection Sales by Geographic Region (2018-2023) & (K Units)
Table 28. Global Trastuzumab Injection Sales Market Share Geographic Region (2018-2023)
Table 29. Global Trastuzumab Injection Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Trastuzumab Injection Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Trastuzumab Injection Sales by Country/Region (2018-2023) & (K Units)
Table 32. Global Trastuzumab Injection Sales Market Share by Country/Region (2018-2023)
Table 33. Global Trastuzumab Injection Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Trastuzumab Injection Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Trastuzumab Injection Sales by Country (2018-2023) & (K Units)
Table 36. Americas Trastuzumab Injection Sales Market Share by Country (2018-2023)
Table 37. Americas Trastuzumab Injection Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Trastuzumab Injection Revenue Market Share by Country (2018-2023)
Table 39. Americas Trastuzumab Injection Sales by Type (2018-2023) & (K Units)
Table 40. Americas Trastuzumab Injection Sales by Application (2018-2023) & (K Units)
Table 41. APAC Trastuzumab Injection Sales by Region (2018-2023) & (K Units)
Table 42. APAC Trastuzumab Injection Sales Market Share by Region (2018-2023)
Table 43. APAC Trastuzumab Injection Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Trastuzumab Injection Revenue Market Share by Region (2018-2023)
Table 45. APAC Trastuzumab Injection Sales by Type (2018-2023) & (K Units)
Table 46. APAC Trastuzumab Injection Sales by Application (2018-2023) & (K Units)
Table 47. Europe Trastuzumab Injection Sales by Country (2018-2023) & (K Units)
Table 48. Europe Trastuzumab Injection Sales Market Share by Country (2018-2023)
Table 49. Europe Trastuzumab Injection Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Trastuzumab Injection Revenue Market Share by Country (2018-2023)
Table 51. Europe Trastuzumab Injection Sales by Type (2018-2023) & (K Units)
Table 52. Europe Trastuzumab Injection Sales by Application (2018-2023) & (K Units)
Table 53. Middle East & Africa Trastuzumab Injection Sales by Country (2018-2023) & (K Units)
Table 54. Middle East & Africa Trastuzumab Injection Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Trastuzumab Injection Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Trastuzumab Injection Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Trastuzumab Injection Sales by Type (2018-2023) & (K Units)
Table 58. Middle East & Africa Trastuzumab Injection Sales by Application (2018-2023) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Trastuzumab Injection
Table 60. Key Market Challenges & Risks of Trastuzumab Injection
Table 61. Key Industry Trends of Trastuzumab Injection
Table 62. Trastuzumab Injection Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Trastuzumab Injection Distributors List
Table 65. Trastuzumab Injection Customer List
Table 66. Global Trastuzumab Injection Sales Forecast by Region (2024-2029) & (K Units)
Table 67. Global Trastuzumab Injection Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Trastuzumab Injection Sales Forecast by Country (2024-2029) & (K Units)
Table 69. Americas Trastuzumab Injection Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Trastuzumab Injection Sales Forecast by Region (2024-2029) & (K Units)
Table 71. APAC Trastuzumab Injection Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Trastuzumab Injection Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Europe Trastuzumab Injection Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Trastuzumab Injection Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Middle East & Africa Trastuzumab Injection Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Trastuzumab Injection Sales Forecast by Type (2024-2029) & (K Units)
Table 77. Global Trastuzumab Injection Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Trastuzumab Injection Sales Forecast by Application (2024-2029) & (K Units)
Table 79. Global Trastuzumab Injection Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Pfizer Basic Information, Trastuzumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 81. Pfizer Trastuzumab Injection Product Portfolios and Specifications
Table 82. Pfizer Trastuzumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Pfizer Main Business
Table 84. Pfizer Latest Developments
Table 85. Roche Basic Information, Trastuzumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 86. Roche Trastuzumab Injection Product Portfolios and Specifications
Table 87. Roche Trastuzumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Roche Main Business
Table 89. Roche Latest Developments
Table 90. Celltrion Basic Information, Trastuzumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 91. Celltrion Trastuzumab Injection Product Portfolios and Specifications
Table 92. Celltrion Trastuzumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Celltrion Main Business
Table 94. Celltrion Latest Developments
Table 95. Amgen Basic Information, Trastuzumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 96. Amgen Trastuzumab Injection Product Portfolios and Specifications
Table 97. Amgen Trastuzumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Amgen Main Business
Table 99. Amgen Latest Developments
Table 100. Samsung Bioepsis Basic Information, Trastuzumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 101. Samsung Bioepsis Trastuzumab Injection Product Portfolios and Specifications
Table 102. Samsung Bioepsis Trastuzumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Samsung Bioepsis Main Business
Table 104. Samsung Bioepsis Latest Developments
Table 105. Mylan Basic Information, Trastuzumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 106. Mylan Trastuzumab Injection Product Portfolios and Specifications
Table 107. Mylan Trastuzumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Mylan Main Business
Table 109. Mylan Latest Developments
Table 110. Glenmark Basic Information, Trastuzumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 111. Glenmark Trastuzumab Injection Product Portfolios and Specifications
Table 112. Glenmark Trastuzumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Glenmark Main Business
Table 114. Glenmark Latest Developments
Table 115. AstraZeneca Basic Information, Trastuzumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 116. AstraZeneca Trastuzumab Injection Product Portfolios and Specifications
Table 117. AstraZeneca Trastuzumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. AstraZeneca Main Business
Table 119. AstraZeneca Latest Developments
Table 120. Remegen Co., Ltd. Basic Information, Trastuzumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 121. Remegen Co., Ltd. Trastuzumab Injection Product Portfolios and Specifications
Table 122. Remegen Co., Ltd. Trastuzumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Remegen Co., Ltd. Main Business
Table 124. Remegen Co., Ltd. Latest Developments
Table 125. Hisun Biopharmaceutical Basic Information, Trastuzumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 126. Hisun Biopharmaceutical Trastuzumab Injection Product Portfolios and Specifications
Table 127. Hisun Biopharmaceutical Trastuzumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Hisun Biopharmaceutical Main Business
Table 129. Hisun Biopharmaceutical Latest Developments
Table 130. Shanghai Henlius Biotech Basic Information, Trastuzumab Injection Manufacturing Base, Sales Area and Its Competitors
Table 131. Shanghai Henlius Biotech Trastuzumab Injection Product Portfolios and Specifications
Table 132. Shanghai Henlius Biotech Trastuzumab Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Shanghai Henlius Biotech Main Business
Table 134. Shanghai Henlius Biotech Latest Developments
List of Figures
Figure 1. Picture of Trastuzumab Injection
Figure 2. Trastuzumab Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Trastuzumab Injection Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Trastuzumab Injection Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Trastuzumab Injection Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 60 mg
Figure 10. Product Picture of 150 mg
Figure 11. Product Picture of 440 mg
Figure 12. Product Picture of Others
Figure 13. Global Trastuzumab Injection Sales Market Share by Type in 2022
Figure 14. Global Trastuzumab Injection Revenue Market Share by Type (2018-2023)
Figure 15. Trastuzumab Injection Consumed in Hospitals
Figure 16. Global Trastuzumab Injection Market: Hospitals (2018-2023) & (K Units)
Figure 17. Trastuzumab Injection Consumed in Clinics
Figure 18. Global Trastuzumab Injection Market: Clinics (2018-2023) & (K Units)
Figure 19. Trastuzumab Injection Consumed in Others
Figure 20. Global Trastuzumab Injection Market: Others (2018-2023) & (K Units)
Figure 21. Global Trastuzumab Injection Sales Market Share by Application (2022)
Figure 22. Global Trastuzumab Injection Revenue Market Share by Application in 2022
Figure 23. Trastuzumab Injection Sales Market by Company in 2022 (K Units)
Figure 24. Global Trastuzumab Injection Sales Market Share by Company in 2022
Figure 25. Trastuzumab Injection Revenue Market by Company in 2022 ($ Million)
Figure 26. Global Trastuzumab Injection Revenue Market Share by Company in 2022
Figure 27. Global Trastuzumab Injection Sales Market Share by Geographic Region (2018-2023)
Figure 28. Global Trastuzumab Injection Revenue Market Share by Geographic Region in 2022
Figure 29. Americas Trastuzumab Injection Sales 2018-2023 (K Units)
Figure 30. Americas Trastuzumab Injection Revenue 2018-2023 ($ Millions)
Figure 31. APAC Trastuzumab Injection Sales 2018-2023 (K Units)
Figure 32. APAC Trastuzumab Injection Revenue 2018-2023 ($ Millions)
Figure 33. Europe Trastuzumab Injection Sales 2018-2023 (K Units)
Figure 34. Europe Trastuzumab Injection Revenue 2018-2023 ($ Millions)
Figure 35. Middle East & Africa Trastuzumab Injection Sales 2018-2023 (K Units)
Figure 36. Middle East & Africa Trastuzumab Injection Revenue 2018-2023 ($ Millions)
Figure 37. Americas Trastuzumab Injection Sales Market Share by Country in 2022
Figure 38. Americas Trastuzumab Injection Revenue Market Share by Country in 2022
Figure 39. Americas Trastuzumab Injection Sales Market Share by Type (2018-2023)
Figure 40. Americas Trastuzumab Injection Sales Market Share by Application (2018-2023)
Figure 41. United States Trastuzumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 42. Canada Trastuzumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 43. Mexico Trastuzumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 44. Brazil Trastuzumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 45. APAC Trastuzumab Injection Sales Market Share by Region in 2022
Figure 46. APAC Trastuzumab Injection Revenue Market Share by Regions in 2022
Figure 47. APAC Trastuzumab Injection Sales Market Share by Type (2018-2023)
Figure 48. APAC Trastuzumab Injection Sales Market Share by Application (2018-2023)
Figure 49. China Trastuzumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 50. Japan Trastuzumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 51. South Korea Trastuzumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 52. Southeast Asia Trastuzumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 53. India Trastuzumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 54. Australia Trastuzumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 55. China Taiwan Trastuzumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 56. Europe Trastuzumab Injection Sales Market Share by Country in 2022
Figure 57. Europe Trastuzumab Injection Revenue Market Share by Country in 2022
Figure 58. Europe Trastuzumab Injection Sales Market Share by Type (2018-2023)
Figure 59. Europe Trastuzumab Injection Sales Market Share by Application (2018-2023)
Figure 60. Germany Trastuzumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 61. France Trastuzumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 62. UK Trastuzumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 63. Italy Trastuzumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 64. Russia Trastuzumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 65. Middle East & Africa Trastuzumab Injection Sales Market Share by Country in 2022
Figure 66. Middle East & Africa Trastuzumab Injection Revenue Market Share by Country in 2022
Figure 67. Middle East & Africa Trastuzumab Injection Sales Market Share by Type (2018-2023)
Figure 68. Middle East & Africa Trastuzumab Injection Sales Market Share by Application (2018-2023)
Figure 69. Egypt Trastuzumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 70. South Africa Trastuzumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 71. Israel Trastuzumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 72. Turkey Trastuzumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 73. GCC Country Trastuzumab Injection Revenue Growth 2018-2023 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Trastuzumab Injection in 2022
Figure 75. Manufacturing Process Analysis of Trastuzumab Injection
Figure 76. Industry Chain Structure of Trastuzumab Injection
Figure 77. Channels of Distribution
Figure 78. Global Trastuzumab Injection Sales Market Forecast by Region (2024-2029)
Figure 79. Global Trastuzumab Injection Revenue Market Share Forecast by Region (2024-2029)
Figure 80. Global Trastuzumab Injection Sales Market Share Forecast by Type (2024-2029)
Figure 81. Global Trastuzumab Injection Revenue Market Share Forecast by Type (2024-2029)
Figure 82. Global Trastuzumab Injection Sales Market Share Forecast by Application (2024-2029)
Figure 83. Global Trastuzumab Injection Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界のトラスツズマブ注射市場予測 2023年-2029年] (コード:LP23DC01521)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のトラスツズマブ注射市場予測 2023年-2029年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆